Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Other Non Operating Income (2023 - 2024)

Historic Other Non Operating Income for Eton Pharmaceuticals (ETON) over the last 3 years, with Q4 2024 value amounting to $169000.0.

  • Eton Pharmaceuticals' Other Non Operating Income rose 12112.5% to $169000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $169000.0, marking a year-over-year change of. This contributed to the annual value of $169000.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Eton Pharmaceuticals reported Other Non Operating Income of $169000.0 as of Q4 2024, which was up 12112.5% from -$800000.0 recorded in Q4 2023.
  • In the past 5 years, Eton Pharmaceuticals' Other Non Operating Income registered a high of $800000.0 during Q2 2023, and its lowest value of -$800000.0 during Q4 2023.
  • In the last 3 years, Eton Pharmaceuticals' Other Non Operating Income had a median value of $267000.0 in 2021 and averaged $133500.0.
  • Over the last 5 years, Eton Pharmaceuticals' Other Non Operating Income had its largest YoY gain of 12112.5% in 2024, and its largest YoY loss of 12112.5% in 2024.
  • Quarter analysis of 3 years shows Eton Pharmaceuticals' Other Non Operating Income stood at $365000.0 in 2021, then tumbled by 319.18% to -$800000.0 in 2023, then skyrocketed by 121.12% to $169000.0 in 2024.
  • Its last three reported values are $169000.0 in Q4 2024, -$800000.0 for Q4 2023, and $800000.0 during Q2 2023.